» Articles » PMID: 12604793

Interferon-inducible Gene Expression Signature in Peripheral Blood Cells of Patients with Severe Lupus

Overview
Specialty Science
Date 2003 Feb 27
PMID 12604793
Citations 1006
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic lupus erythematosus (SLE) is a complex, inflammatory autoimmune disease that affects multiple organ systems. We used global gene expression profiling of peripheral blood mononuclear cells to identify distinct patterns of gene expression that distinguish most SLE patients from healthy controls. Strikingly, about half of the patients studied showed dysregulated expression of genes in the IFN pathway. Furthermore, this IFN gene expression "signature" served as a marker for more severe disease involving the kidneys, hematopoetic cells, and/or the central nervous system. These results provide insights into the genetic pathways underlying SLE, and identify a subgroup of patients who may benefit from therapies targeting the IFN pathway.

Citing Articles

Enhancement of CD8T cell cytotoxicity activity by IFN-α implies alternative pathologic role in systemic lupus erythematosus.

Zhang C, Mao Y, Tan Y, Zhang M, Shao K, Wang S J Transl Autoimmun. 2025; 10:100276.

PMID: 39995790 PMC: 11849641. DOI: 10.1016/j.jtauto.2025.100276.


Evaluation of IRF7 mRNA and its Association with Promoter Methylation in Kashmiri (North-Indian) Patients with Systemic Sclerosis: A Case-Control Study.

Ayub S, Shah Z, Sofi F, Rasool R, Shafi T, Dangroo M Mediterr J Rheumatol. 2025; 35(4):645-652.

PMID: 39886279 PMC: 11778618. DOI: 10.31138/mjr.040124.eoi.


An essential role for TASL in mouse autoimmune pathogenesis and Toll-like receptor signaling.

Lau L, Cariaga T, Chang A, Lane J, Purtha W, Rapaport A Nat Commun. 2025; 16(1):968.

PMID: 39856038 PMC: 11760370. DOI: 10.1038/s41467-024-55690-0.


Alterations in genes associated with cytosolic RNA sensing in whole blood are associated with coronary microvascular disease in SLE.

Huo L, Kumar A, Tumurkhuu G, Bose M, Berman D, Wallace D Sci Rep. 2025; 15(1):2457.

PMID: 39828802 PMC: 11743764. DOI: 10.1038/s41598-024-82190-4.


Opportunities and limitations of B cell depletion approaches in SLE.

Stockfelt M, Teng Y, Vital E Nat Rev Rheumatol. 2025; 21(2):111-126.

PMID: 39815102 DOI: 10.1038/s41584-024-01210-9.


References
1.
Fukuyama S, Kajiwara E, Suzuki N, Miyazaki N, Sadoshima S, Onoyama K . Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: a case report and review of the literature. Am J Gastroenterol. 2000; 95(1):310-2. DOI: 10.1111/j.1572-0241.2000.01715.x. View

2.
Harley J, Moser K, Gaffney P, Behrens T . The genetics of human systemic lupus erythematosus. Curr Opin Immunol. 1999; 10(6):690-6. DOI: 10.1016/s0952-7915(98)80090-3. View

3.
Rozzo S, Allard J, Choubey D, Vyse T, Izui S, Peltz G . Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity. 2001; 15(3):435-43. DOI: 10.1016/s1074-7613(01)00196-0. View

4.
Blanco P, Palucka A, Gill M, Pascual V, Banchereau J . Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science. 2001; 294(5546):1540-3. DOI: 10.1126/science.1064890. View

5.
Ronnblom L, Alm G . A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med. 2001; 194(12):F59-63. PMC: 2193578. DOI: 10.1084/jem.194.12.f59. View